pyruvaldehyde and s-4-bromobenzylglutathione cyclopentyl diester

pyruvaldehyde has been researched along with s-4-bromobenzylglutathione cyclopentyl diester in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Beguinot, F; D'Esposito, V; Fiory, F; Fleming, TH; Formisano, P; Leone, A; Longo, M; Miele, C; Mirra, P; Nawroth, PP; Nigro, C; Prevenzano, I; Raciti, GA; Ulianich, L1
Hollenbach, M; Michel, M; Pohl, S; Ripoll, C; Thonig, A; Zipprich, A1
Rabbani, N; Thornalley, PJ1

Reviews

1 review(s) available for pyruvaldehyde and s-4-bromobenzylglutathione cyclopentyl diester

ArticleYear
Emerging Glycation-Based Therapeutics-Glyoxalase 1 Inducers and Glyoxalase 1 Inhibitors.
    International journal of molecular sciences, 2022, Feb-23, Volume: 23, Issue:5

    Topics: Animals; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Enzyme Induction; Glutathione; Glycosylation; Hesperidin; Humans; Insulin Resistance; Lactoylglutathione Lyase; Mice; Molecular Structure; Neoplasms, Experimental; Obesity; Pyruvaldehyde; Resveratrol

2022

Other Studies

2 other study(ies) available for pyruvaldehyde and s-4-bromobenzylglutathione cyclopentyl diester

ArticleYear
Methylglyoxal impairs endothelial insulin sensitivity both in vitro and in vivo.
    Diabetologia, 2014, Volume: 57, Issue:7

    Topics: Animals; Endothelial Cells; Glutathione; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Mice; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyruvaldehyde; Signal Transduction

2014
Expression of glyoxalase-I is reduced in cirrhotic livers: A possible mechanism in the development of cirrhosis.
    PloS one, 2017, Volume: 12, Issue:2

    Topics: Animals; Cells, Cultured; Cytokines; Glutathione; Inflammation; Lactoylglutathione Lyase; Liver; Liver Cirrhosis; Male; NF-kappa B; Pyruvaldehyde; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha

2017